On January 21 and February 26, 2016, the 17th and 18th participants completed their 12-month long-term follow-up interviews in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD in Boulder, Colorado. All subjects have now completed active study participation. Long-term follow-up data will provide additional information to guide the design of our upcoming Phase 3 trials. Study participant Hania Withem will present a brief address at MAPS’ upcoming 30th Anniversary Banquet and Celebration on April 17 at the Scottish Rite Center in Oakland, Calif. (tickets available now). The final results will be prepared for publication in the first half of 2016, with publication expected later in 2016.
